Open AccessPrediction and prevention of Type 1 diabetes mellitus
Author(s) -
ZHANG Li,
EISENBARTH George S.
Publication year - 2011
Publication title -
journal of diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.949
H-Index - 43
eISSN - 1753-0407
pISSN - 1753-0393
DOI - 10.1111/j.1753-0407.2010.00102.x
Subject(s) - medicine , insulinoma , islet , autoantibody , type 1 diabetes , diabetes mellitus , glutamate decarboxylase , insulin , endocrinology , clinical trial , antibody , immunology , biochemistry , enzyme , biology
Type 1A diabetes mellitus (T1DM) is caused by autoimmune islet β‐cell destruction with consequent severe insulin deficiency. We can now predict the development of T1DM by determining four biochemically characterized islet autoantibodies, namely those antibodies against insulin, glutamic acid decarboxylase 65, insulinoma antigen (IA)‐2 (ICA512) and the zinc transporter ZnT8. We can also prevent T1DM in animal models, but the final goal is the prevention of T1DM in humans. Multiple clinical trials are underway investigating methods to prevent β‐cell destruction.